[1]
Aslam, Z. et al. 2019. Evaluation of Serum Circulating Levels of ICAM-1 as Tuberculosis Risk-assessment Factor in Type 2 Diabetes Patients. Puerto Rico Health Sciences Journal. 38, 1 (Mar. 2019), 22–26.